Research Projects

Prospective, multicenter, open-label study to evaluate the efficacy of esmolol in the early identification of cardiovascular disorders induced by cirrhosis, diabetes mellitus and cardiotoxic treatments (bB-ECHO).


Project information

To study the efficacy of esmolol in the early identification of cardiovascular alterations induced by cirrhosis, diabetes mellitus, and cardiotoxic treatments.

Esmolol is a drug used in routine medical practice for the treatment of cardiac arrhythmias or in serious situations where it is necessary to rapidly control arterial hypertension.

  • Reference: bB-ECHO
  • Start date: 1 de january de 2021
  • End date: 31 de december de 2024
  • Funded by: Carlos III Health Institute
  • Type: Nacional

Need more information?

If you are interested in learning more about our research, please contact us.